O	0	12	Differential	Differential	JJ	B-NP
O	13	22	secretion	secretion	NN	I-NP
O	23	25	of	of	IN	B-PP
O	26	34	proteins	protein	NNS	B-NP
O	35	38	and	and	CC	I-NP
O	39	52	glycoproteins	glycoprotein	NNS	I-NP
O	53	55	by	by	IN	B-PP
B-Organ	56	62	livers	liver	NNS	B-NP
O	63	65	of	of	IN	B-PP
O	66	74	immature	immature	JJ	B-NP
O	75	78	and	and	CC	I-NP
O	79	84	adult	adult	JJ	I-NP
O	85	89	rats	rat	NNS	I-NP
O	89	90	.	.	.	O

O	91	97	Effect	Effect	NN	B-NP
O	98	100	of	of	IN	B-PP
B-Cellular_component	101	116	antimicrotubule	antimicrotubule	JJ	B-NP
O	117	122	drugs	drug	NNS	I-NP
O	122	123	.	.	.	O

O	124	128	This	This	DT	B-NP
O	129	134	study	study	NN	I-NP
O	135	138	was	be	VBD	B-VP
O	139	148	initiated	initiate	VBN	I-VP
O	149	151	to	to	TO	B-PP
O	152	154	re	re	AFX	B-NP
O	154	155	-	-	HYPH	I-NP
O	155	162	examine	examine	NN	I-NP
O	163	171	reported	report	VBD	B-VP
O	172	183	differences	difference	NNS	B-NP
O	184	186	in	in	IN	B-PP
O	187	190	the	the	DT	B-NP
O	191	197	action	action	NN	I-NP
O	198	200	of	of	IN	B-PP
B-Cellular_component	201	216	antimicrotubule	antimicrotubule	JJ	B-NP
O	217	223	agents	agent	NNS	I-NP
O	224	226	on	on	IN	B-PP
B-Organism_substance	227	233	plasma	plasma	NN	B-NP
O	234	241	protein	protein	NN	I-NP
O	242	251	secretion	secretion	NN	I-NP
O	252	256	from	from	IN	B-PP
B-Organ	257	263	livers	liver	NNS	B-NP
O	264	266	of	of	IN	B-PP
O	267	275	immature	immature	JJ	B-NP
O	276	282	versus	versus	IN	B-PP
O	283	288	adult	adult	JJ	B-NP
O	289	293	rats	rat	NNS	I-NP
O	293	294	.	.	.	O

O	295	298	The	The	DT	B-NP
O	299	302	aim	aim	NN	I-NP
O	303	306	was	be	VBD	B-VP
O	307	308	(	(	(	B-LST
O	308	309	1	1	LS	I-LST
O	309	310	)	)	)	O
O	311	313	to	to	TO	B-VP
O	314	323	determine	determine	VB	I-VP
O	324	327	the	the	DT	B-NP
O	328	339	composition	composition	NN	I-NP
O	340	343	and	and	CC	O
O	344	346	to	to	TO	B-VP
O	347	354	monitor	monitor	VB	I-VP
O	355	358	the	the	DT	B-NP
O	359	368	secretion	secretion	NN	I-NP
O	369	371	of	of	IN	B-PP
O	372	379	various	various	JJ	B-NP
B-Organism_substance	380	386	plasma	plasma	NN	I-NP
O	387	395	proteins	protein	NNS	I-NP
O	396	399	and	and	CC	I-NP
O	400	413	glycoproteins	glycoprotein	NNS	I-NP
O	414	418	from	from	IN	B-PP
B-Multi-tissue_structure	419	424	liver	liver	NN	B-NP
I-Multi-tissue_structure	425	431	slices	slice	NNS	I-NP
O	432	439	labeled	label	VBN	B-VP
O	440	442	in	in	FW	B-ADVP
O	443	448	vitro	vitro	FW	I-ADVP
O	449	453	with	with	IN	B-PP
O	454	462	specific	specific	JJ	B-NP
O	463	468	amino	amino	NN	I-NP
O	469	474	acids	acid	NNS	I-NP
O	475	478	and	and	CC	O
O	479	484	sugar	sugar	NN	B-NP
O	485	493	residues	residue	NNS	I-NP
O	493	494	,	,	,	O
O	495	498	and	and	CC	O
O	499	500	(	(	(	B-LST
O	500	501	2	2	LS	I-LST
O	501	502	)	)	)	O
O	503	505	to	to	TO	B-VP
O	506	515	correlate	correlate	VB	I-VP
O	516	524	observed	observe	VBN	B-NP
O	525	536	differences	difference	NNS	I-NP
O	537	539	in	in	IN	B-PP
O	540	549	secretion	secretion	NN	B-NP
O	550	552	of	of	IN	B-PP
O	553	558	these	these	DT	B-NP
O	559	567	proteins	protein	NNS	I-NP
O	568	572	with	with	IN	B-PP
O	573	583	structural	structural	JJ	B-NP
O	584	591	changes	change	NNS	I-NP
O	592	594	in	in	IN	B-PP
O	595	598	the	the	DT	B-NP
B-Cell	599	610	hepatocytes	hepatocyte	NNS	I-NP
O	611	613	of	of	IN	B-PP
O	614	617	the	the	DT	B-NP
O	618	627	different	different	JJ	I-NP
O	628	632	aged	aged	JJ	I-NP
O	633	640	animals	animal	NNS	I-NP
O	640	641	.	.	.	O

O	642	645	For	For	IN	B-PP
O	646	649	the	the	DT	B-NP
O	650	654	most	most	JJS	I-NP
O	655	659	part	part	NN	I-NP
O	659	660	,	,	,	O
B-Multi-tissue_structure	661	667	slices	slice	NNS	B-NP
O	668	670	of	of	IN	B-PP
B-Organ	671	676	liver	liver	NN	B-NP
O	677	681	from	from	IN	B-PP
B-Developing_anatomical_structure	682	687	fetal	fetal	JJ	B-NP
O	688	689	(	(	(	O
O	689	693	term	term	NN	B-NP
O	693	694	)	)	)	O
O	694	695	,	,	,	O
O	696	704	neonatal	neonatal	JJ	B-ADJP
O	705	706	(	(	(	O
O	706	707	4	4	CD	B-NP
O	707	708	-	-	HYPH	B-ADJP
O	709	711	to	to	TO	B-PP
O	712	713	5	5	CD	B-NP
O	714	718	days	day	NNS	I-NP
O	719	722	old	old	JJ	B-ADJP
O	722	723	)	)	)	O
O	723	724	,	,	,	O
O	725	728	and	and	CC	O
O	729	734	adult	adult	JJ	B-NP
O	735	739	rats	rat	NNS	I-NP
O	740	741	(	(	(	O
O	741	743	70	70	CD	B-NP
O	744	748	days	day	NNS	I-NP
O	749	752	old	old	JJ	B-ADJP
O	752	753	)	)	)	O
O	754	758	were	be	VBD	B-VP
O	759	768	incubated	incubate	VBN	I-VP
O	769	773	with	with	IN	B-PP
O	774	785	radioactive	radioactive	JJ	B-NP
O	786	791	amino	amino	NN	I-NP
O	792	797	acids	acid	NNS	I-NP
O	798	800	or	or	CC	O
O	801	808	various	various	JJ	B-NP
O	809	818	tritiated	tritiated	JJ	I-NP
O	819	825	sugars	sugar	NNS	I-NP
O	826	834	specific	specific	JJ	B-ADJP
O	835	838	for	for	IN	B-PP
O	839	840	N	N	NN	B-NP
O	840	841	-	-	HYPH	O
O	841	847	linked	link	VBN	B-NP
O	848	852	core	core	NN	I-NP
O	853	868	oligosaccharide	oligosaccharide	NN	I-NP
O	869	872	and	and	CC	O
O	872	873	/	/	SYM	B-NP
O	873	875	or	or	CC	O
O	876	877	N	N	NN	B-NP
O	877	878	-	-	HYPH	B-VP
O	878	884	linked	link	VBN	I-VP
O	885	893	terminal	terminal	JJ	B-NP
O	894	909	oligosaccharide	oligosaccharide	NN	I-NP
O	910	916	chains	chain	NNS	I-NP
O	916	917	.	.	.	O

O	918	921	Our	Our	PRP$	B-NP
O	922	930	findings	finding	NNS	I-NP
O	931	939	indicate	indicate	VBP	B-VP
O	940	944	that	that	IN	B-SBAR
B-Multi-tissue_structure	945	950	liver	liver	NN	B-NP
I-Multi-tissue_structure	951	957	slices	slice	NNS	I-NP
O	958	960	of	of	IN	B-PP
B-Developing_anatomical_structure	961	966	fetal	fetal	JJ	B-NP
O	967	970	and	and	CC	I-NP
O	971	979	neonatal	neonatal	JJ	I-NP
O	980	984	rats	rat	NNS	I-NP
O	985	988	are	be	VBP	B-VP
O	989	998	efficient	efficient	JJ	B-ADJP
O	999	1001	in	in	IN	B-PP
O	1002	1014	synthesizing	synthesize	VBG	B-VP
B-Organism_substance	1015	1021	plasma	plasma	NN	B-NP
O	1022	1030	proteins	protein	NNS	I-NP
O	1031	1040	including	include	VBG	B-PP
O	1041	1046	fully	fully	RB	B-NP
O	1047	1059	glycosylated	glycosylate	VBN	I-NP
O	1060	1073	glycoproteins	glycoprotein	NNS	I-NP
O	1073	1074	.	.	.	O

O	1075	1078	The	The	DT	B-NP
O	1079	1088	secretion	secretion	NN	I-NP
O	1089	1091	of	of	IN	B-PP
O	1092	1104	glycosylated	glycosylate	VBN	B-NP
O	1105	1108	and	and	CC	I-NP
O	1109	1124	nonglycosylated	nonglycosylate	VBN	I-NP
O	1125	1133	proteins	protein	NNS	I-NP
O	1134	1142	believed	believe	VBN	B-VP
O	1143	1145	to	to	TO	I-VP
O	1146	1148	be	be	VB	I-VP
O	1149	1158	processed	process	VBN	I-VP
O	1159	1166	through	through	IN	B-PP
B-Cellular_component	1167	1172	Golgi	Golgi	NNP	B-NP
I-Cellular_component	1173	1182	complexes	complex	NNS	I-NP
O	1183	1186	was	be	VBD	B-VP
O	1187	1196	inhibited	inhibit	VBN	I-VP
O	1197	1199	to	to	TO	B-PP
O	1200	1203	the	the	DT	B-NP
O	1204	1208	same	same	JJ	I-NP
O	1209	1215	extent	extent	NN	I-NP
O	1216	1217	(	(	(	O
O	1217	1230	approximately	approximately	RB	B-NP
O	1231	1233	70	70	CD	I-NP
O	1233	1234	-	-	HYPH	I-NP
O	1234	1236	80	80	CD	I-NP
O	1236	1237	%	%	NN	I-NP
O	1237	1238	)	)	)	O
O	1239	1241	by	by	IN	B-PP
B-Cellular_component	1242	1257	antimicrotubule	antimicrotubule	JJ	B-NP
O	1258	1264	agents	agent	NNS	I-NP
O	1264	1265	,	,	,	O
O	1266	1276	regardless	regardless	RB	B-ADVP
O	1277	1279	of	of	IN	B-PP
O	1280	1283	the	the	DT	B-NP
O	1284	1287	age	age	NN	I-NP
O	1288	1290	of	of	IN	B-PP
O	1291	1294	the	the	DT	B-NP
O	1295	1299	host	host	NN	I-NP
O	1300	1306	animal	animal	NN	I-NP
O	1306	1307	.	.	.	O

O	1308	1315	However	However	RB	B-ADVP
O	1315	1316	,	,	,	O
O	1317	1322	other	other	JJ	B-NP
O	1323	1331	proteins	protein	NNS	I-NP
O	1332	1335	and	and	CC	I-NP
O	1336	1349	glycoproteins	glycoprotein	NNS	I-NP
O	1350	1358	secreted	secrete	VBN	B-VP
O	1359	1361	by	by	IN	B-PP
B-Organ	1362	1368	livers	liver	NNS	B-NP
O	1369	1371	of	of	IN	B-PP
O	1372	1380	immature	immature	JJ	B-NP
O	1381	1385	rats	rat	NNS	I-NP
O	1386	1390	were	be	VBD	B-VP
O	1391	1396	found	find	VBN	I-VP
O	1397	1399	to	to	TO	I-VP
O	1400	1402	be	be	VB	I-VP
O	1403	1413	relatively	relatively	RB	B-ADJP
O	1414	1425	insensitive	insensitive	JJ	I-ADJP
O	1426	1427	(	(	(	O
O	1427	1428	i	i	JJ	B-NP
O	1428	1429	.	.	.	I-NP
O	1429	1430	e	e	NN	I-NP
O	1430	1431	.	.	.	O
O	1432	1441	inhibited	inhibit	VBD	B-VP
O	1442	1444	to	to	TO	B-PP
O	1445	1449	only	only	RB	B-NP
O	1450	1452	30	30	CD	I-NP
O	1452	1453	-	-	HYPH	I-NP
O	1453	1455	40	40	CD	I-NP
O	1455	1456	%	%	NN	I-NP
O	1456	1457	)	)	)	O
O	1458	1460	to	to	TO	B-PP
O	1461	1464	the	the	DT	B-NP
O	1465	1471	action	action	NN	I-NP
O	1472	1474	of	of	IN	B-PP
O	1475	1482	various	various	JJ	B-NP
B-Cellular_component	1483	1498	antimicrotubule	antimicrotubule	JJ	I-NP
O	1499	1504	drugs	drug	NNS	I-NP
O	1504	1505	.	.	.	O

O	1506	1509	The	The	DT	B-NP
O	1510	1523	glycoproteins	glycoprotein	NNS	I-NP
O	1524	1528	were	be	VBD	B-VP
O	1529	1534	found	find	VBN	I-VP
O	1535	1537	to	to	TO	I-VP
O	1538	1542	lack	lack	VB	I-VP
O	1543	1544	N	N	NN	B-NP
O	1544	1545	-	-	HYPH	B-VP
O	1545	1551	linked	link	VBN	B-NP
O	1552	1560	terminal	terminal	JJ	I-NP
O	1561	1567	sugars	sugar	NNS	I-NP
O	1568	1569	(	(	(	O
O	1569	1577	although	although	IN	B-SBAR
O	1578	1581	the	the	DT	B-NP
O	1582	1595	glycoproteins	glycoprotein	NNS	I-NP
O	1596	1599	did	do	VBD	B-VP
O	1600	1607	contain	contain	VB	I-VP
O	1608	1609	N	N	NN	B-NP
O	1609	1610	-	-	HYPH	O
O	1610	1616	linked	link	VBN	B-NP
O	1617	1621	core	core	NN	I-NP
O	1622	1628	sugars	sugar	NNS	I-NP
O	1628	1629	)	)	)	O
O	1629	1630	,	,	,	O
O	1631	1634	and	and	CC	O
O	1635	1637	it	it	PRP	B-NP
O	1638	1640	is	be	VBZ	B-VP
O	1641	1647	likely	likely	JJ	B-ADJP
O	1648	1652	that	that	IN	B-SBAR
O	1653	1656	the	the	DT	B-NP
O	1657	1661	drug	drug	NN	I-NP
O	1661	1662	-	-	HYPH	B-NP
O	1662	1673	insensitive	insensitive	JJ	I-NP
O	1674	1682	proteins	protein	NNS	I-NP
O	1683	1691	bypassed	bypass	VBD	B-VP
O	1692	1700	critical	critical	JJ	B-NP
O	1701	1714	glycosylating	glycosylate	VBG	I-NP
O	1715	1720	sites	site	NNS	I-NP
O	1721	1723	in	in	IN	B-PP
O	1724	1727	the	the	DT	B-NP
B-Cellular_component	1728	1733	Golgi	Golgi	NNP	I-NP
I-Cellular_component	1734	1745	compartment	compartment	NN	I-NP
O	1746	1751	prior	prior	RB	B-ADVP
O	1752	1754	to	to	TO	B-VP
O	1755	1762	release	release	VB	I-VP
O	1762	1763	.	.	.	O

O	1764	1771	Overall	Overall	RB	B-ADVP
O	1771	1772	,	,	,	O
O	1773	1778	these	these	DT	B-NP
O	1779	1787	findings	finding	NNS	I-NP
O	1788	1795	support	support	VBP	B-VP
O	1796	1803	earlier	early	JJR	B-NP
O	1804	1808	data	datum	NNS	I-NP
O	1809	1816	showing	show	VBG	B-VP
O	1817	1821	that	that	IN	B-SBAR
B-Cellular_component	1822	1837	antimicrotubule	antimicrotubule	JJ	B-NP
O	1838	1843	drugs	drug	NNS	I-NP
O	1844	1848	have	have	VBP	B-VP
O	1849	1850	a	a	DT	B-NP
O	1851	1858	special	special	JJ	I-NP
O	1859	1865	impact	impact	NN	I-NP
O	1866	1868	on	on	IN	B-PP
B-Cellular_component	1869	1874	Golgi	Golgi	NNP	B-NP
O	1874	1875	-	-	HYPH	O
O	1875	1885	associated	associate	VBN	B-VP
O	1886	1892	events	event	NNS	B-NP
O	1893	1895	in	in	IN	B-PP
B-Cell	1896	1901	liver	liver	NN	B-NP
I-Cell	1902	1907	cells	cell	NNS	I-NP
O	1907	1908	.	.	.	O

O	1909	1911	To	To	TO	B-PP
O	1912	1916	what	what	WDT	B-NP
O	1917	1923	extent	extent	NN	I-NP
O	1924	1929	these	these	DT	B-NP
O	1930	1938	findings	finding	NNS	I-NP
O	1939	1942	are	be	VBP	B-VP
O	1943	1950	related	relate	VBN	I-VP
O	1951	1953	to	to	TO	B-PP
O	1954	1957	the	the	DT	B-NP
O	1958	1964	action	action	NN	I-NP
O	1965	1967	of	of	IN	B-PP
B-Cellular_component	1968	1980	microtubules	microtubule	NNS	B-NP
O	1981	1988	remains	remain	VBZ	B-VP
O	1989	1991	to	to	TO	I-VP
O	1992	1994	be	be	VB	I-VP
O	1995	1999	seen	see	VBN	I-VP
O	1999	2000	.	.	.	O

